@dr.jon.l

@dr.jon.l has been a member of Linktree for 5 years and joined in February 2021. The social media accounts linked to from @dr.jon.l are: • Instagram • TikTok • Threads • Bluesky Besides social media accounts, Drjonl has populated their site with: • Canadian Guidelines on Sexually Transmitted Infections - Canada.ca • John Hopkins University COVID-19 Resource Centre • Recommended immunization schedules: Canadian Immunization Guide - Canada.ca • National Advisory Committee on Immunization (NACI): Statements and publications - Canada.ca • Thrombosis Canada • Home | immunizecanada • RESOURCES | Researching for 2SLGBTQA+ Health • Canadian Tuberculosis Standards 7th Edition: 2014 - Canada.ca • Laboratory data: Respiratory virus trends — Canada.ca • Public Health Agency of Canada Website • NEJM Effectiveness of Vaccines Against Delta Variant (UK) • SCCS from England with no increased risk death after mRN vaccines in young people • Reuters SM-102 Factcheck (Follow links in Article) • SCCS from Bologna with no increased risk of death after mRNA vaccines • Health Canada Astra-Zeneca Vaccine Info • No increased risk sudden cardiac death in the NCAA after vaccines available • Ontario Public Health Breakthrough Case Document • Hungary study showing reductions in all-cause death from COVID vaccines • CDC MMWR Risk Reinfection versus Vaccine Study • No Association Between COVID Vaccines and Out of Hospital Cardiac Arrests in Australia • Spain Mixing AstraZeneca and Pfizer Vaccine Trial • Rate and Cause of Sudden Cardiac Death in the Young During the COVID-19 Pandemic and Vaccination • Lancet Autoimmune Disease and COVID Vaccine Antibody Response • Byram Bridle Factcheck Page with Links • Mask Scientific Review • Together Trial Presentation on Ivermectin • Bangladesh Mask Study • Priority Patients for Early Treatment of COVID (monoclonal antibodies and antiviral pills) • Public Health Ontario - Evidence Summary on Mask Mandates and COVID • Pfizer COVID Vaccine Safety Monitoring Document (First of the FOIA releases) • Ontario Public Health Recommendations for COVID Vaccine Booster Doses (Includes List of Immunocompromising Conditions and Medications) • PNAS Evidence Review of the Effectiveness of Masks • NEJM NBA study showing faster clearance of Delta in Vaccinated People • 70 Studies on Masks (stolen from @thatsassynp) • Go Fund Me for Blackfoot Clean Water in Alberta • Mask Meta-analysis 1 • Israel Ministry of Health COVID Dashboard • CDC MMWR Comparing Counties with and without Mask Mandates • WODGIE Website - Worldwide Ivermectin Ban! • CDC Scientific Brief on Community Use of Masks • NACI Updated Statement on Bivalent Boosters for the Fall 2022 • JAMA Effectiveness of Masks on Community Spread • NACI Bivalent COVID Vaccine Recommendations (Includes Table of High-Risk Conditions Prioritized for Boosters) • Principle Ivermectin Trial • ACTIV-6 Ivermectin Trial Published Trial (JAMA) • NEJM COVID-OUT Trial (Ivermectin, Metformin, Fluvoxamine) • Updated Cochrane Review on Ivermectin and COVID-19 (2022) • ATIV-6 Ivermectin and COVID-19 RCT • JAMA Ivermectin, COVID and Strongyloides meta-analysis • JAMA I-TECH Ivermectin Randomized Control Trial • Hill's Full Ivermectin Meta-analysis Revised (removed ElGazzar trial) • Hill Ivermectin Re-Analysis (After Meta-Analysis was Withdrawn due to fraudulent trials) • Cochrane Systematic Review and Meta-Analysis on Ivermectin for COVID-19 • IDSA Ivermectin Meta-Analysis • NEJM Effectiveness of vaccine verses no vaccine after previous infection • Timeline of mRNA vaccine technology and Malone's place in it • RCT Moderna Vaccine • RCT Pfizer Vaccine • EMA Pfizer Vaccine Briefing Document that Includes Information about Biodistribution Studies • Israel COVID Vaccine Study • California COVID Vaccine Effectiveness Study • Texas COVID Vaccine Effectiveness Study • Moderna Animal Study • Pfizer Animal Study • Lancet Vaccine ARR versus RRR Explained • Health Canada Pfizer mRNA Vaccine Info • Health Canada Moderna mRNA Vaccine Info • Health Canada Novavax Information (Including Ingredients) • Novovax Vaccine Trial (NEJM) • Circulation Study (Patrone et al) comparing Myocarditis after Vaccine and COVID in the UK • Comment on the Swedish mRNA Vaccine Converted into DNA study • Biostatistician Fact-Checking Steve Kirsch and VAERS Claims • JAMA Myocarditis after COVID-19 Trial • Commentary on BMJ article about Pfizer Trial • NEJM Israel Vaccine Safety study • Pregnancy and COVID Vaccines Study • Health Canada Vaccine Safety Monitoring • VAERS FAQ • American Heart Association/Circulation Review Of Myocarditis with COVID Vaccine • NEJM Remdesivir Early Treatment for COVID RCT • Nirmatrelvir/Ritonavir (Paxlovid) NEJM Trial • Health Canada Summary on Nirmatrelvir/Ritonavir (Paxlovid) • WHO Solidarity Trial (Repurposed Drugs for Treatment of COVID-19) • JAMA Vitamin D Level of COVID-19 • Hydroxychloroquine Meta-Analysis • IDSA COVID Treatment Guidelines • NIH COVID-19 Treatment Guidelines • Alberta Health Services Document Vitamin D and COVID • JAMA Review of Short- and Long-term rates of Long COVID • BMJ Review on Long COVID • Lancet 6-month Consequences of COVID infection (Long-COVID) • CDC Summary of the Omicron Variant • JAMA Excess Mortality and Leading Causes of Death 2020 • Ontario Cycle Threshold Document • Isolation of SARS-CoV-2 Study US • CDC MMWR Risk Reinfection Previous Infection vs Vaccines • No Anti-Syncytin Antibodies after COVID vaccine • Pre-Print Vaccine Effectiveness Against Variants of Concern in Canada • Manitoba Shared Health Patient Transfer to Other Provinces • NACI Mixing Vaccines Document • SARS-CoV-1 Animal Trial (2012) • Article About Modifications to Vaccine Spike Protein • Stats Canada Provisional Weekly Death Counts • Canadian Vaccination Rate • CDC Vaccine Efficacy and Effectiveness Summary • NACI Extended Dosing Intervals • Thrombosis Canada VIPIT Guide • Ontario Briefing on VIPIT • NACI AstraZeneca Vaccine Rapid Response • CDC Document on Reporting COVID-19 Deaths • Alberta Health Services Ivermectin and COVID document • Health Canada Janssen (JnJ) Vaccine Info • Vaccine development Infographic • Haematology.org on ATTACC trial